Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003236 · ClinicalTrials.gov registry record · Phase 2
Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer
A Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003236: Completed Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
NCT00003236 is a Phase 2 study that has completed, run by Eastern Cooperative Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003236, a Phase 2 study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of ISIS 5132 with ISIS 3521 in treating women who have metastatic breast cancer that has not responded to previous therapy.
Interventions
- BIOLOGICAL ISIS 3521
- DRUG ISIS 5132
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-07-13 |
| Phase | Phase 2 |
What the finished NCT00003236 record still lists
NCT00003236 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which ISIS 3521 is the first listed.
NCT00003236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003236 about?
NCT00003236 is a clinical study titled "Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of ISIS 5132 with ISIS 3521 in treating women who have metastatic breast cancer that has not responded to previous ...
What is the current status of trial NCT00003236?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-07-13.
What interventions are being tested in trial NCT00003236?
The interventions under investigation include: ISIS 3521 (BIOLOGICAL), ISIS 5132 (DRUG).
Who is sponsoring clinical trial NCT00003236?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI